Management of melanomas in children and young adults

Journal of Pediatric Hematology/Oncology

Volumn 34, Issue SUPPL. 2, 2012, Pages

  Neier, Michelle ^a   Pappo, Alberto ^b   Navid, Fariba ^b  

^a Goryeb Children's Hospital   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

children; Melanoma; young adults

Indexed keywords

ALPHA2B INTERFERON; CARBOPLATIN; CISPLATIN; DACARBAZINE; INTERLEUKIN 2; IPILIMUMAB; PACLITAXEL; PLEX 4032; TEMOZOLOMIDE; UNCLASSIFIED DRUG; VEMURAFENIB; VINBLASTINE;

ADULT; AMELANOTIC MELANOMA; B RAF GENE; CANCER INCIDENCE; CANCER INVASION; CANCER PREVENTION; CANCER SCREENING; CANCER STAGING; CHILD; CHROMOSOME DELETION; COMPUTER ASSISTED TOMOGRAPHY; DISTANT METASTASIS; DRUG MEGADOSE; FAMILY HISTORY; GENE; GENE MUTATION; HEALTH EDUCATION; HUMAN; LONG TERM SURVIVAL; LYMPH NODE METASTASIS; MELANOCYTIC NEVUS; MELANOMA; MICROSATELLITE INSTABILITY; NEUTROPENIA; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE SURVIVAL; REVIEW; SELF EXAMINATION; SENTINEL LYMPH NODE BIOPSY; SUN EXPOSURE; SUNLIGHT PROTECTION; SURVIVAL RATE;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MELANOMA; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; YOUNG ADULT;

EID: 84860304252     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31824e3852     Document Type: Review

References (49)

1. Ries LA, Smith MA, Gurmey JG, et al. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD: National Cancer Institute; 1999:139-147.
2. Herzog C, Pappo A, Bondy M, et al. Malignant melanoma. In: Bleyer A, et al, ed. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 19 Years of Age, Including SEER Incidence and Survival: 1975-2000. NIH Pub. No. 06-5767. Bethesda, MD: National Cancer Institute; 2006:53-63.
3. Strouse JJ, Fears TR, Tucker MA, et al. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemio-logy and end results database. J Clin Oncol. 2005;23: 4735-4741. (Pubitemid 46224077)
4. Pappo AS. Melanoma in children and adolescents. Eur J Cancer. 2003;39:2651-2661. (Pubitemid 37468306)
5. Hansson J. Familial melanoma. viii. Surg Clin North Am. 2008;88:897-916.
6. Hussussian CJ, Struewing JP, Goldstein AM, et al. Germline p16 mutations in familial melanoma. Nat Genet. 1994;8:15-21. (Pubitemid 24274055)
7. Uribe P, Wistuba II, Solar A, et al. Comparative analysis of lossof heterozygosity and microsatellite instability in adult and pediatric melanoma. Am J Dermatopathol. 2005;27:279-285. (Pubitemid 41232477)
8. Harland M, Taylor CF, Bass S, et al. Intronic sequence variants of the CDKN2A gene in melanoma pedigrees. Genes Chromosomes Cancer. 2005;43:128-136. (Pubitemid 40570732)
9. Meyer LJ, Zone JH. Genetics of cutaneous melanoma. JInvest Dermatol. 1994;103(suppl 5):112S-116S. (Pubitemid 24348785)
10. Ceballos PI, Ruiz-Maldonado R, Mihm MC Jr, et al. Melanoma in children. N Engl J Med. 1995;332:656-662.
11. Ivry GB, Ogle CA, Shim EK. Role of sun exposure in melanoma. Dermatol Surg. 2006;32:481-492.
12. Naeyaert JM, Brochez L. Clinical practice. Dysplastic nevi. N Engl J Med. 2003;349:2233-2240.
13. Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. N Engl J Med. 2004;351:998-1012.
14. Demko CA, Borawski EA, Debanne SM, et al. Use of indoor tanning facilities by white adolescents in the United States. Arch Pediatr Adolesc Med. 2003;157:854-860. (Pubitemid 37082294)
15. Pacheco I, Buzea C, Tron V. Towards new therapeutic approaches for malignant melanoma. Expert Rev Mol Med. 2011;13:e33.
16. Ferrari A, Bono A, Baldi M, et al. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution. Pediatrics. 2005;115:649-654. (Pubitemid 43373024)
17. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199-6206.
18. Lange JR, Palis BE, Chang DC, et al. Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base. J Clin Oncol. 2007;25:1363-1368. (Pubitemid 46706883)
19. Livestro DP, Kaine EM, Michaelson JS, et al. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis. Cancer. 2007;110:614-624. (Pubitemid 47106151)
20. Blazer DG III, Sondak VK, Sabel MS. Surgical therapy of cutaneous melanoma. Semin Oncol. 2007;34:270-280. (Pubitemid 46874553)
21. Butter A, Hui T, Chapdelaine J, et al. Melanoma in children and the use of sentinel lymph node biopsy. J Pediatr Surg. 2005;40:797-800. (Pubitemid 40724850)
22. Navid F, Furman WL, Fleming M, et al. The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma. Cancer. 2005;103:780-787. (Pubitemid 40216407)
23. Roaten JB, Partrick DA, Pearlman N, et al. Sentinel lymph node biopsy for melanoma and other melanocytic tumors in adolescents. JPediatr Surg. 2005;40:232-235. (Pubitemid 40143564)
24. Murali R, Sharma RN, Thompson JF, et al. Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors). Ann Surg Oncol. 2008;15:302-309.
25. Zuckerman R, Maier JP, Guiney WB Jr, et al. Pediatric melanoma: confirming the diagnosis with sentinel node biopsy. Ann Plast Surg. 2001;46:394-399. (Pubitemid 32319677)
26. Geelhoed GW, Breslow A, McCune WS. Malignant melano-ma: correlation of long-term follow-up with clinical staging, level of invasion and thickness of the primary tumor. Am Surg. 1977;43:77-85. (Pubitemid 8033189)
27. Kayton ML, La Quaglia MP. Sentinel node biopsy for melanocytic tumors in children. Semin Diagn Pathol. 2008; 25:95-99. (Pubitemid 351885459)
28. Roaten JB, Partrick DA, Bensard D, et al. Survival in sentinel lymph node-positive pediatric melanoma. JPediatr Surg. 2005; 40:988-992. (Pubitemid 40846472)
29. Toro J, Ranieri JM, Havlik RJ, et al. Sentinel lymph node biopsy in children and adolescents with malignant melanoma. JPediatr Surg. 2003;38:1063-1065. (Pubitemid 36828876)
30. Buzaid AC, Sandler AB, Mani S, et al. Role of computed tomography in the staging ofprimary melanoma. J Clin Oncol. 1993;11:638-643. (Pubitemid 23105671)
31. Kaste SC, Pappo AS, Jenkins JJ III, et al. Malignant melanoma in children: imaging spectrum. Pediatr Radiol. 1996;26:800-805. (Pubitemid 26383702)
32. Krug B, Crott R, Lonneux M, et al. Role of PET in the initial staging of cutaneous malignant melanoma: systematic review. Radiology. 2008;249:836-844.
33. Balch CM, Soong SJ, Murad TM, et al. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg. 1981;193:377-388. (Pubitemid 11114057)
34. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635-3648. (Pubitemid 32786276)
35. Milton GW, Shaw HM, Thompson JF, et al. Cutaneous melanoma in childhood: incidence and prognosis. Australas J Dermatol. 1997;1:S44-S48.
36. Rao BN, Hayes FA, Pratt CB, et al. Malignant melanoma in children: its management and prognosis. J Pediatr Surg. 1990;25:198-203. (Pubitemid 20046188)
37. Saenz NC, Saenz-Badillos J, Busam K, et al. Childhood melanoma survival. Cancer. 1999;85:750-754. (Pubitemid 29075297)
38. Schmid-Wendtner MH, Berking C, Baumert J, et al. Cuta-neous melanoma in childhood and adolescence: an analysis of 36 patients. JAm Acad Dermatol. 2002;46:874-879.
39. Hancock BW, Wheatley K, Harris S, et al. Adjuvant interferon in high-risk melanoma: the AIM HIGH Study\United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma. J Clin Oncol. 2004;22:53-61. (Pubitemid 41095114)
40. Kirkwood JM, Ibrahim JG, Sondak VK, et al. High-and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol. 2000;18: 2444-2458. (Pubitemid 30415832)
41. Kirkwood JM, Strawderman MH, Ernstoff MS, et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol. 1996;14:7-17. (Pubitemid 26019991)
42. Chao MM, Schwartz JL, Wechsler DS, et al. High-risk surgically resected pediatric melanoma and adjuvant interferon therapy. Pediatr Blood Cancer. 2005;44:441-448. (Pubitemid 40614491)
43. Shah NC, Gerstle JT, Stuart M, et al. Use of sentinel lymph node biopsy and high-dose interferon in pediatric patients with high-risk melanoma: the Hospital for Sick Children experience. JPediatr Hematol Oncol. 2006;28:496-500. (Pubitemid 44257995)
44. Atkins MB, Lotze MT, Dutcher JP, et al. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J Clin Oncol. 1999;17:2105-2116. (Pubitemid 29318842)
45. Roper M, Smith MA, Sondel PM, et al. A phase I study of interleukin-2 in children with cancer. Am J Pediatr Hematol Oncol. 1992;14:305-311.
46. Leo F, Cagini L, Rocmans P, et al. Lung metastases from melanoma: when is surgical treatment warranted? Br J Cancer. 2000;83:569-572. (Pubitemid 30636294)
47. Ollila DW, Hsueh EC, Stern SL, et al. Metastasectomy for recurrent stage IV melanoma. J Surg Oncol. 1999;71: 209-213. (Pubitemid 29388015)
48. Page DB, Yuan J, Wolchok JD. Targeting cytotoxic T-lymphocyte antigen 4 in immunotherapies for melanoma and other cancers. Immunotherapy. 2010;2:367-379.
49. Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364:2507-2516.